Loading data
ZNTLNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 67.43 m USD | 0 USD | 0 USD | — |
| Research and development expense | 107.3 m USD | 167.77 m USD | 189.59 m USD | 172.73 m USD | 175.6 m USD |
| Operating profit | -152.81 m USD | -191.19 m USD | -299.51 m USD | -227.29 m USD | -216.54 m USD |
| Profit before tax | -136.62 m USD | -165.69 m USD | -292.91 m USD | -237.58 m USD | -166.39 m USD |
| Income tax expense | 442 k USD | 177 k USD | -601 k USD | -469 k USD | -297 k USD |
| Net income (reported basis) | -137.06 m USD | -165.87 m USD | -292.31 m USD | -237.11 m USD | -166.09 m USD |
| Basic earnings per share | -1.91 USD/share | -2.33 USD/share | -4.47 USD/share | -4.48 USD/share | -3.72 USD/share |
| Diluted earnings per share | -1.91 USD/share | -2.33 USD/share | -4.47 USD/share | -4.48 USD/share | -3.72 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.